
Dr. Rajesh Kumar Ahlawat is a highly distinguished Urology & Andrology specialist serving as Group Chairman - Urology at Max Super Speciality Hospital, Delhi. With over 20 years of dedicated clinical experience, Dr. Rajesh Kumar Ahlawat has built an outstanding reputation for delivering precision-focused, patient-centred care to both domestic and international patients from over 50 countries.
Trained at premier medical institutions across India and having completed advanced fellowship training in Urology & Andrology, Dr. Rajesh Kumar Ahlawat brings exceptional depth of expertise to every case. The doctor's commitment to minimally invasive, evidence-based techniques ensures the best possible outcomes with faster recovery and minimal complications for all patients.
Dr. Rajesh Kumar Ahlawat and the team at Max Super Speciality Hospital, Delhi, regularly receive patients from Africa, the Middle East, Central Asia, and Europe who seek world-class treatment at a fraction of Western costs. International patients benefit from free visa assistance, dedicated airport transfers, multilingual coordinator support, transparent cost estimates, and structured tele-follow-up after returning home.
Operating at a JCI and NABH accredited hospital, Dr. Rajesh Kumar Ahlawat combines the highest international standards of patient safety with a deeply personalised approach. Every case is individually reviewed, and treatment plans are discussed in full detail before any decisions or travel arrangements are made.
Decades of expertise, proven results, and compassionate care — here is why patients from 50+ countries trust Dr. Rajesh Kumar Ahlawat for Urology & Andrology treatment in India.
Over 20 years of dedicated clinical experience with 5,000+ procedures. One of the most trusted names in Urology & Andrology in India.
Dr. Rajesh Kumar Ahlawat regularly treats patients from Africa, the Middle East, Central Asia, and Europe. Dedicated international patient support team available 24/7.
Practices at an internationally accredited hospital, ensuring patient safety standards that match the best hospitals in the USA and Europe.
World-class treatment at a fraction of USA, UK, or Australian prices. Transparent cost estimates provided before you travel.
Dr. Rajesh Kumar Ahlawat holds postgraduate qualifications from premier Indian institutions and has advanced fellowship training in Urology & Andrology.
Every case is personally reviewed. Treatment plans are tailored, transparent, and discussed in detail before you make any decisions or travel arrangements.
Microsurgical and laparoscopic varicocele correction with high success rates for fertility restoration.
Microsurgical vasovasostomy and vasoepididymostomy with high patency and fertility rates.
Comprehensive evaluation and surgical sperm retrieval (TESA, PESA, Micro-TESE) for ART procedures.
Robotic prostatectomy, robotic nephrectomy, and robotic pyeloplasty using da Vinci system.
Living donor and cadaveric kidney transplants including ABO-incompatible transplant.
Robotic radical prostatectomy, focal therapy, and minimally invasive treatment of prostate cancer.
PCNL, URS, ESWL for all sizes and types of kidney stones.
Bladder cancer surgery, urinary incontinence, and overactive bladder treatment.
Hypospadias repair, undescended testes, and congenital urological anomalies in children.
Microsurgical and laparoscopic varicocele correction restoring normal sperm parameters and fertility.
Microsurgical restoration of fertility after vasectomy using multi-layer anastomosis techniques.
Minimally invasive urological procedures using robotic (da Vinci) and laparoscopic techniques.
Living donor and cadaveric kidney transplants with comprehensive post-transplant care.
Advanced techniques for retrieving sperm in men with azoospermia for use in IVF/ICSI.
Send your medical reports and get a personalised treatment plan. The team reviews cases from 50+ countries and responds within 24 hours.
Our team responds within 24 hours
Share your reports and receive a personalised treatment recommendation within 48 hours — at no cost.